News
Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...
Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.
3d
TipRanks on MSNQuantum BioPharma purchases 2,000 shares of GameStopQuantum BioPharma (QNTM) announced the purchase of 2,000 shares of GameStop (GME) to hold on the Company’s balance sheet as a strategic ...
“The Quantum team and I see the extreme value in GameStop going forward and the deep value the company has with 90% cash and marketable securities on their balance sheet,” said Kevin Malone, Board ...
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, ... In 2021, when multiple brokerages removed the buy button on GameStop, ...
Quantum BioPharma Ltd., a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced it has renewed the services of King Tide Media LLC ...
Quantum BioPharma is considered a low-float stock with just 1.83 million shares available for public trading, according to Benzinga Pro. The company also had a market cap of approximately $6 ...
Hosted on MSN5mon
Quantum BioPharma stock soars on clinical trial success - MSNInvesting.com -- Shares of Quantum (NASDAQ:QMCO) BioPharma Ltd. (NASDAQ: QNTM) surged 95% following the announcement of positive results from its clinical trial for the dietary supplement unbuzzd™.
Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results